Skip to content

Clinical trials

Terminated Cardiotoxicity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiotoxicity Status: Terminated Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20062
20082
20091
20111
20142
20161
20193
20213
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Washington University School of Medicine2
AHS Cancer Control Alberta1
Algemeen Ziekenhuis Maria Middelares1
Avera McKennan Hospital & University Health Center1
Cedars-Sinai Medical Center1
GERCOR - Multidisciplinary Oncology Cooperative Group1
Hellenic Oncology Research Group1
IRCCS Policlinico S. Donato1
Insel Gruppe AG, University Hospital Bern1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiotoxicity21
Breast Neoplasms10
Heart Failure3
Neoplasms3
Heart Diseases2
Lymphoma2
Sarcoma2
Atherosclerosis1
Breast Diseases1
COVID-191

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.